ABIOMED Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
134 / 663
Position in country
2650 / 14179
Return on Assets, %
16
-11.9
Net income margin, %
39.9
-12.5
EBITDA margin, %
24.3
-2.5
Debt to Equity, %
0
15
Intangible assets and goodwill, %
7.2
3.9
Revenue CAGR 3Y, %
10.2
12.6
Total Equity change 1Y, %
0
0
Revenue Y, % chg
0
4.6
P/BV
12.5
1.7
EV/EBITDA
50.2
-0.2
Payout Ratio, %
0
17.3
Competitors
Ranks
-
Dexcom Inc
00%
-
ABIOMED Inc
00%
-
Boston Scientific Corp
00%
-
Intuitive Surgical Inc
00%
-
Stryker Corp
00%
-
Edwards Lifesciences Corp
00%
-
IDEXX Laboratories Inc
00%
-
Abbott Laboratories
00%
-
GE Healthcare Technologies Inc
00%
-
Becton Dickinson and Co
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
17180.6
Ticker
ABMD.O
ISIN
US0036541003
IPO date
Availability on Russian exchanges
No
Reporting for
2022-11-03
Date fact. publication of reports
2022-09-30
Company Description
ABIOMED, Inc. is a provider of medical devices, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to improve blood flow and/or performing the pumping function of the heart. Its products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. Its operating segment includes the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. Its existing products include Impella 2.5, Impella CP, Impella 5.0 and Impella LD. The Impella 2.5 device is a percutaneous micro heart pump with an integrated motor and sensors. The Impella CP device provides blood flow of approximately one liter more per minute than the Impella 2.5 device.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: